Bortezomib CAS NO.179324-69-7

high quality

Bortezomib Basic information

Product Name:	Bortezomib
Synonyms:	VELCADE;dpba;BORTEZOMIB;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Bortezomib for research;Bortezomib ( Velcade, MG-341, PS-341 )
CAS:	179324-69-7
MF:	C19H25BN4O4
MW:	384.24
EINECS:
Product Categories:	Boron Derivatives;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Pepetides;ProteasomeInhibitors;Apis;Inhibitor;Final material;API;peptides
Mol File:	179324-69-7.mol

Bortezomib Chemical Properties

mp	122-124°C
density	1.214
storage temp.	Hygroscopic, -20°C Freezer, Under Inert Atmosphere
Stability:	Hygroscopic and Moisture Sensitive
CAS DataBase Reference	179324-69-7(CAS DataBase Reference)

Safety Information

Hazardous Substances Data

MSDS Information

Bortezomib Usage And Synthesis

Chemical Properties	Yellow Solid
Usage	Bortezomib is the first proteasome inhibitor to be approved b the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. T
Usage	Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle foun d in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
Usage	selective proteasome inhibitor

Bortezomib Preparation Products And Raw materials